Case Study: AstraZeneca achieves an ethical, more visible and efficient procurement transformation with JAGGAER

AstraZeneca An Ethical Procurement Transformation

AstraZeneca, the global, science-led biopharmaceutical company that manages roughly $14bn in external spend, needed to raise the credibility and visibility of its procurement function, simplify complex processes for internal stakeholders, and rapidly respond to supply‑chain disruption during COVID‑19 while also tackling sustainability, supplier diversity and inflationary risk. To unify source-to-contract processes and gain better commercial insight, AstraZeneca adopted the JAGGAER source-to-contract platform.

JAGGAER provided a backbone repository with forecasting, analytics and supplier management capabilities that enabled AstraZeneca to monitor category strategies, track future value and improve transparency and collaboration across its supplier ecosystem. Although the case study does not disclose specific ROI figures, AstraZeneca reports clearer spend visibility, more effective value‑tracking, streamlined contracting and stronger supplier engagement — measurable improvements in procurement decision‑making and risk/sustainability management driven by JAGGAER.

AstraZeneca

John Dickson

Chief Procurement Officer